Tag: Organogenesis Inc

Kekst Works Avista’s Wound Care Deal

Kekst & Co is handling Avista Capital Markets private equity firm’s merger of a “blank check company” with Organogenesis Inc. advanced wound care and sports medicine operation.

 

ACM has agreed to invest $92M in Canton, MA-based Organogenesis, which is expected to trade on the NASDAQ with an enterprise value in the $675M range when the deal closes by the end of the year.

 

Organogenesis has more than 600 employees involved in the development, manufacture and commercialization of products in the regenerative medicine sector.

 

Tom Dean, CEO of Avista Healthcare Public Acquisition Corp., said Organogenesis is “well-positioned to benefit from secular tailwinds driving the advance would care, surgical and sports medicine sectors.” … news release from O’Dwyer’s

Organogenesis Showcases New Product Offerings

and Research at SAWC Spring 2018

 

CANTON, Mass. and CHARLOTTE, N.C., April 24, 2018 /PRNewswire/ — The latest advanced wound care research and product offerings from Organogenesis Inc. – including the recently-launched PuraPly® Antimicrobial 1.6 cm small size – will be showcased during the nation’s largest interdisciplinary wound care forum, the Symposium on Advanced Wound Care Spring | Wound Healing Society (SAWC Spring | WHS) meeting, held April 25-29 in Charlotte, NC.

 

Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets, will feature its full suite of advanced wound care and surgical biologic product offerings at exhibit booth #419.

 

Scientific presentations will feature several products within the Organogenesis portfolio, and exhibit booth attendees will have the chance to learn more about the company’s comprehensive wound care portfolio designed to empower personalized healing for a wide variety of wound types across the wound care continuum.

 

Organogenesis is also a proud sponsor of the Thursday, April 26 Lunch Symposium, “Understanding the Latest Evidence: A Fresh Look at the Use of Skin Substitutes Across the Wound Care Continuum,” featuring speakers Daniel Kapp, MD; George Koullias, MD; and Katie C. Mowry, PhD.

Original Press Release on PR Newswire